Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 3
2008 1
2009 1
2010 5
2011 2
2012 2
2013 4
2014 5
2015 5
2016 1
2017 3
2018 3
2019 3
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mireiaolivan (1 results)?
A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG.
Rodríguez-Barrueco R, Latorre J, Devis-Jáuregui L, Lluch A, Bonifaci N, Llobet FJ, Olivan M, Coll-Iglesias L, Gassner K, Davis ML, Moreno-Navarrete JM, Castells-Nobau A, Plata-Peña L, Dalmau-Pastor M, Höring M, Liebisch G, Olkkonen VM, Arnoriaga-Rodríguez M, Ricart W, Fernández-Real JM, Silva JM, Ortega FJ, Llobet-Navas D. Rodríguez-Barrueco R, et al. Among authors: olivan m. Adv Sci (Weinh). 2022 Feb;9(4):e2104759. doi: 10.1002/advs.202104759. Epub 2021 Dec 13. Adv Sci (Weinh). 2022. PMID: 34898027 Free PMC article.
The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models.
Masanas M, Masiá N, Suárez-Cabrera L, Olivan M, Soriano A, Majem B, Devis-Jauregui L, Burgos-Panadero R, Jiménez C, Rodriguez-Sodupe P, Boloix A, Toledano I, Guillén G, Navarro A, Llobet-Navas D, Villanueva A, Sánchez de Toledo J, Roma J, Noguera R, Moreno L, Krauss R, Gallego S, Santamaria A, Segura MF. Masanas M, et al. Among authors: olivan m. Clin Transl Med. 2021 Oct;11(10):e533. doi: 10.1002/ctm2.533. Clin Transl Med. 2021. PMID: 34709738 Free PMC article. No abstract available.
Methodology for the at-home collection of urine samples for prostate cancer detection.
Webb M, Manley K, Olivan M, Guldvik I, Palczynska M, Hurst R, Connell SP, Mills IG, Brewer DS, Mills R, Cooper CS, Clark J. Webb M, et al. Among authors: olivan m. Biotechniques. 2020 Feb;68(2):65-71. doi: 10.2144/btn-2019-0092. Epub 2019 Nov 29. Biotechniques. 2020. PMID: 31779479 Free article. Clinical Trial.
A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
Connell SP, Yazbek-Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I; Movember GAP1 Urine Biomarker Consortium; Parker C, Brewer DS, Cooper CS, Clark J. Connell SP, et al. BJU Int. 2019 Oct;124(4):609-620. doi: 10.1111/bju.14811. Epub 2019 Jun 25. BJU Int. 2019. PMID: 31106513 Free PMC article.
Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer.
Puig P, Erill N, Terricabras M, Subirana I, González-García J, Asensi-Puig A, Donovan MJ, Mengual L, Agulló-Ortuño MT, Olivan M, Alcaraz A, López-Martín JA, de Torres I, Rodríguez-Peralto JL, Rodríguez-Antolín A, Morote J, González-Rumayor V. Puig P, et al. Among authors: olivan m. BMC Res Notes. 2019 Jan 30;12(1):68. doi: 10.1186/s13104-019-4100-z. BMC Res Notes. 2019. PMID: 30700322 Free PMC article.
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F, Olkhov-Mitsel E, Kamdar S, Jeyapala R, Garcia J, Hurst R, Hanna MY, Mills R, Tuzova AV, O'Reilly E, Kelly S, Cooper C; Movember Urine Biomarker Consortium; Brewer D, Perry AS, Clark J, Fleshner N, Bapat B. Zhao F, et al. Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z. Clin Epigenetics. 2018. PMID: 30470249 Free PMC article.
Low-dose statin treatment increases prostate cancer aggressiveness.
Caro-Maldonado A, Camacho L, Zabala-Letona A, Torrano V, Fernández-Ruiz S, Zamacola-Bascaran K, Arreal L, Valcárcel-Jiménez L, Martín-Martín N, Flores JM, Cortazar AR, Zúñiga-García P, Arruabarrena-Aristorena A, Guillaumond F, Cabrera D, Falcón-Perez JM, Aransay AM, Gomez-Muñoz A, Olivan M, Morote J, Carracedo A. Caro-Maldonado A, et al. Among authors: olivan m. Oncotarget. 2017 Oct 31;9(2):1494-1504. doi: 10.18632/oncotarget.22217. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416709 Free PMC article.
39 results